SWM
Spire Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.6K | Sell |
83
-97
| -54% | -$50.9K | ﹤0.01% | 1255 |
|
|
2025
Q1 | $114K | Buy |
180
+22
| +14% | +$14K | ﹤0.01% | 988 |
|
|
2024
Q4 | $113K | Buy |
158
+13
| +9% | +$9.26K | ﹤0.01% | 990 |
|
|
2024
Q3 | $152K | Buy |
145
+29
| +25% | +$30.5K | 0.01% | 802 |
|
|
2024
Q2 | $122K | Sell |
116
-62
| -35% | -$65K | ﹤0.01% | 843 |
|
|
2024
Q1 | $171K | Sell |
178
-8
| -4% | -$7.69K | ﹤0.01% | 815 |
|
|
2023
Q4 | $174K | Sell |
186
-5
| -3% | -$4.67K | 0.01% | 800 |
|
|
2023
Q3 | $157K | Sell |
191
-8,756
| -98% | -$7.21M | 0.01% | 786 |
|
|
2023
Q2 | $6.43M | Buy |
8,947
+159
| +2% | +$114K | 0.24% | 87 |
|
|
2023
Q1 | $7.22M | Buy |
8,788
+8,639
| +5,798% | +$7.1M | 0.28% | 78 |
|
|
2022
Q4 | $108K | Buy |
149
+57
| +62% | +$41.3K | 0.01% | 717 |
|
|
2022
Q3 | $63K | Sell |
92
-499
| -84% | -$342K | ﹤0.01% | 869 |
|
|
2022
Q2 | $349K | Sell |
591
-100
| -14% | -$59.1K | 0.01% | 584 |
|
|
2022
Q1 | $483K | Sell |
691
-144
| -17% | -$101K | 0.01% | 586 |
|
|
2021
Q4 | $527K | Buy |
835
+159
| +24% | +$100K | 0.01% | 684 |
|
|
2021
Q3 | $410K | Buy |
676
+446
| +194% | +$271K | 0.01% | 659 |
|
|
2021
Q2 | $128K | Sell |
230
-214
| -48% | -$119K | ﹤0.01% | 1100 |
|
|
2021
Q1 | $211K | Buy |
+444
| New | +$211K | 0.01% | 1043 |
|